Nearly 8 in 10 Tested U.S. Typhoid Cases Resisted Ciprofloxacin, a Longtime First-Line Antibiotic
A CDC-led JAMA Network Open study found 78.4% of U.S. typhoid samples from 2016 to 2020 were not susceptible to ciprofloxacin, a longtime first-line antibiotic.